155 related articles for article (PubMed ID: 29063338)
21. The thrombin-fibrinogen interaction.
Scheraga HA
Biophys Chem; 2004 Dec; 112(2-3):117-30. PubMed ID: 15572239
[TBL] [Abstract][Full Text] [Related]
22. The effects of pH on the generation of turbidity and elasticity associated with fibrinogen-fibrin conversion by thrombin are remarkably influenced by sialic acid in fibrinogen.
Okude M; Yamanaka A; Akihama S
Biol Pharm Bull; 1995 Feb; 18(2):203-7. PubMed ID: 7742784
[TBL] [Abstract][Full Text] [Related]
23. Bound thrombin from crushed clots is composed of alpha-thrombin and the N-terminal regions of alpha- and gamma-chains of fibrinogen.
Kinjoh K; Nakamura M; Gang Z; Sunagawa M; Eguchi Y; Kosugi T
Pathophysiol Haemost Thromb; 2002; 32(4):165-73. PubMed ID: 12759517
[TBL] [Abstract][Full Text] [Related]
24. The isolation of fibrinogen monomer dramatically influences fibrin polymerization.
Huang L; Lord ST
Thromb Res; 2013 Jun; 131(6):e258-63. PubMed ID: 23622556
[TBL] [Abstract][Full Text] [Related]
25. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
Liu CZ; Shih MH; Tsai PJ
Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
[TBL] [Abstract][Full Text] [Related]
26. Cl- regulates the structure of the fibrin clot.
Di Stasio E; Nagaswami C; Weisel JW; Di Cera E
Biophys J; 1998 Oct; 75(4):1973-9. PubMed ID: 9746538
[TBL] [Abstract][Full Text] [Related]
27. Spatiotemporal dynamics of fibrin formation and spreading of active thrombin entering non-recalcified plasma by diffusion.
Krasotkina YV; Sinauridze EI; Ataullakhanov FI
Biochim Biophys Acta; 2000 May; 1474(3):337-45. PubMed ID: 10779685
[TBL] [Abstract][Full Text] [Related]
28. Thrombin generation and fibrin clot structure.
Wolberg AS
Blood Rev; 2007 May; 21(3):131-42. PubMed ID: 17208341
[TBL] [Abstract][Full Text] [Related]
29. Fibrin clot properties and haemostatic function in men and women with type 1 diabetes.
Tehrani S; Jörneskog G; Ågren A; Lins PE; Wallén H; Antovic A
Thromb Haemost; 2015 Feb; 113(2):312-8. PubMed ID: 25318636
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogen C-terminal peptidic sequences (Haptides) modulate fibrin polymerization.
Marx G; Ben-Moshe M; Magdassi S; Gorodetsky R
Thromb Haemost; 2004 Jan; 91(1):43-51. PubMed ID: 14691567
[TBL] [Abstract][Full Text] [Related]
31. Binding of carboxypeptidase N to fibrinogen and fibrin.
Talens S; Lebbink JH; Malfliet JJ; Demmers JA; Uitte de Willige S; Leebeek FW; Rijken DC
Biochem Biophys Res Commun; 2012 Oct; 427(2):421-5. PubMed ID: 23000409
[TBL] [Abstract][Full Text] [Related]
32. Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin. (II) Application of enzyme kinetics to turbidimetrical method.
Sato H; Nakajima A
Thromb Res; 1984 Jul; 35(2):133-9. PubMed ID: 6474414
[TBL] [Abstract][Full Text] [Related]
33. Fibrin proliferation at model surfaces: influence of surface properties.
Evans-Nguyen KM; Schoenfisch MH
Langmuir; 2005 Mar; 21(5):1691-4. PubMed ID: 15723458
[TBL] [Abstract][Full Text] [Related]
34. Glucose Concentration Affects Fibrin Clot Structure and Morphology as Evidenced by Fluorescence Imaging and Molecular Simulations.
Hood JE; Yesudasan S; Averett RD
Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):104S-116S. PubMed ID: 30114949
[TBL] [Abstract][Full Text] [Related]
35. Morphometric characterization of fibrinogen's αC regions and their role in fibrin self-assembly and molecular organization.
Protopopova AD; Litvinov RI; Galanakis DK; Nagaswami C; Barinov NA; Mukhitov AR; Klinov DV; Weisel JW
Nanoscale; 2017 Sep; 9(36):13707-13716. PubMed ID: 28884176
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of fibrinogen-coated, reversibly adhesive, lecithin/cholesterol vesicles.
DeAnglis AP; Retzinger GS
J Pharm Sci; 1995 Apr; 84(4):399-403. PubMed ID: 7629727
[TBL] [Abstract][Full Text] [Related]
37. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
Sanchez J; Elgue G; Larsson R; Nilsson B; Olsson P
Thromb Res; 2008; 122(2):257-63. PubMed ID: 18177925
[TBL] [Abstract][Full Text] [Related]
38. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
Soya K; Terasawa F; Okumura N
Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100
[TBL] [Abstract][Full Text] [Related]
39. Decreased fibrinolytic potential and morphological changes of fibrin structure in dermatitis herpetiformis.
Görög A; Németh K; Szabó L; Mayer B; Silló P; Kolev K; Kárpáti S
J Dermatol Sci; 2016 Oct; 84(1):17-23. PubMed ID: 27440075
[TBL] [Abstract][Full Text] [Related]
40. Fibronectin alters the rate of formation and structure of the fibrin matrix.
Ramanathan A; Karuri N
Biochem Biophys Res Commun; 2014 Jan; 443(2):395-9. PubMed ID: 24309108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
